These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 26600633)

  • 41. Benzofuranyl-2-imidazoles as imidazoline I
    Rodriguez-Arévalo S; Bagán A; Griñán-Ferré C; Vasilopoulou F; Pallàs M; Brocos-Mosquera I; Callado LF; Loza MI; Martínez AL; Brea J; Pérez B; Molins E; De Jonghe S; Daelemans D; Radan M; Djikic T; Nikolic K; Hernández-Hernández E; García-Fuster MJ; García-Sevilla JA; Escolano C
    Eur J Med Chem; 2021 Oct; 222():113540. PubMed ID: 34118720
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CR4056, a powerful analgesic imidazoline-2 receptor ligand, inhibits the inflammation-induced PKCε phosphorylation and membrane translocation in sensory neurons.
    Vellani V; Sabatini C; Milia C; Caselli G; Lanza M; Letari O; Rovati LC; Giacomoni C
    Br J Pharmacol; 2020 Jan; 177(1):48-64. PubMed ID: 31454418
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic potential of group III metabotropic glutamate receptor ligands in pain.
    Acher F; Goudet C
    Curr Opin Pharmacol; 2015 Feb; 20():64-72. PubMed ID: 25498980
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of IRAS/Nischarin involved in the development of morphine tolerance and physical dependence.
    Li S; Wu N; Zhao TY; Lu GY; Wang ZY; Li F; Li J
    Biochem Biophys Res Commun; 2019 May; 512(3):460-466. PubMed ID: 30902386
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alleviating pain with delta opioid receptor agonists: evidence from experimental models.
    Berthiaume S; Abdallah K; Blais V; Gendron L
    J Neural Transm (Vienna); 2020 Apr; 127(4):661-672. PubMed ID: 32189076
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Guanidinium and aminoimidazolinium derivatives of N-(4-piperidyl)propanamides as potential ligands for mu opioid and I2-imidazoline receptors: synthesis and pharmacological screening.
    Montero A; Goya P; Jagerovic N; Callado LF; Meana JJ; Girón R; Goicoechea C; Martín MI
    Bioorg Med Chem; 2002 Apr; 10(4):1009-18. PubMed ID: 11836109
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Opioid adjuvant strategy: improving opioid effectiveness.
    Bihel F
    Future Med Chem; 2016; 8(3):339-54. PubMed ID: 26898358
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Shedding Light on the Pharmacological Interactions between μ-Opioid Analgesics and Angiotensin Receptor Modulators: A New Option for Treating Chronic Pain.
    Király K; Karádi DÁ; Zádor F; Mohammadzadeh A; Galambos AR; Balogh M; Riba P; Tábi T; Zádori ZS; Szökő É; Fürst S; Al-Khrasani M
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684749
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biologically active compounds based on the privileged 2-imidazoline scaffold: The world beyond adrenergic/imidazoline receptor modulators.
    Krasavin M
    Eur J Med Chem; 2015 Jun; 97():525-37. PubMed ID: 25466925
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Attenuation of acute and chronic effects of morphine by the imidazoline receptor ligand 2-(2-benzofuranyl)-2-imidazoline in rat locus coeruleus neurons.
    Ruiz-Durántez E; Torrecilla M; Pineda J; Ugedo L
    Br J Pharmacol; 2003 Feb; 138(3):494-500. PubMed ID: 12569074
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The kappa opioid receptor agonist SA14867 has antinociceptive and weak sedative effects in models of acute and chronic pain.
    Tsukahara-Ohsumi Y; Tsuji F; Niwa M; Hata T; Narita M; Suzuki T; Sasano M; Aono H
    Eur J Pharmacol; 2011 Dec; 671(1-3):53-60. PubMed ID: 21970808
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetic-pharmacodynamic modeling in acute and chronic pain: an overview of the recent literature.
    Martini C; Olofsen E; Yassen A; Aarts L; Dahan A
    Expert Rev Clin Pharmacol; 2011 Nov; 4(6):719-28. PubMed ID: 22111858
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Testing conception of engagement of imidazoline receptors in imidazoline drugs effects on isolated rat heart atria.
    Radwanska A; Dlugokecka J; Wasilewski R; Kaliszan R
    J Physiol Pharmacol; 2009 Mar; 60(1):131-42. PubMed ID: 19439815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tapentadol. Acute or chronic pain: no therapeutic advance.
    Prescrire Int; 2014 May; 23(149):121-4. PubMed ID: 24926510
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Implication of delta opioid receptor subtype 2 but not delta opioid receptor subtype 1 in the development of morphine analgesic tolerance in a rat model of chronic inflammatory pain.
    Beaudry H; Gendron L; Morón JA
    Eur J Neurosci; 2015 Apr; 41(7):901--7. PubMed ID: 25639561
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biased Opioid Ligands.
    Faouzi A; Varga BR; Majumdar S
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32948048
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A new tridecapeptide with an octaarginine vector has analgesic therapeutic potential and prevents morphine-induced tolerance.
    Kashkin VA; Shekunova EV; Titov MI; Eliseev II; Gureev MA; Porozov YB; Makarova MN; Makarov VG
    Peptides; 2018 Jan; 99():61-69. PubMed ID: 29175519
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Harms and benefits of opioids for management of non-surgical acute and chronic low back pain: a systematic review.
    Tucker HR; Scaff K; McCloud T; Carlomagno K; Daly K; Garcia A; Cook CE
    Br J Sports Med; 2020 Jun; 54(11):664. PubMed ID: 30902816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel fentanyl-based dual μ/δ-opioid agonists for the treatment of acute and chronic pain.
    Podolsky AT; Sandweiss A; Hu J; Bilsky EJ; Cain JP; Kumirov VK; Lee YS; Hruby VJ; Vardanyan RS; Vanderah TW
    Life Sci; 2013 Dec; 93(25-26):1010-6. PubMed ID: 24084045
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Imaging opioid analgesia in the human brain and its potential relevance for understanding opioid use in chronic pain.
    Lee MC; Wanigasekera V; Tracey I
    Neuropharmacology; 2014 Sep; 84(100):123-30. PubMed ID: 23891639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.